HEAR FROM PEOPLE WITH DIABETES ON TIME IN RANGE (TIR)
Hear real stories from actual patients highlighting the impact of TIR
![TIR HCP Educational Content: Patient Video Lasse](/content/dam/novonordisk/novomedlink/new/diabetes/professional-education/disease/library/images/poster-tir-hcp-educational-content-patient-lasse.jpg)
Patient with type 1 diabetes has received a fee from Novo Nordisk Inc. for his participation.
LASSE’S EXPERIENCE WITH TIR
![headshot of Lasse, a patient with diabetes](/diabetes/hcp-education/clinical/time-in-range/time-in-range-patient-stories/_jcr_content/root/slab_1771630399_copy_278385335/content/container_copy/container_copy/image.img.png/1645291355875/profile-lasse-circle.png)
32 years
Type 1 diabetes, Denmark
![Mary, a patient with diabetes](/diabetes/hcp-education/clinical/time-in-range/time-in-range-patient-stories/_jcr_content/root/slab_1771630399_copy/content/container_copy/container_1161094072/image_copy.img.jpeg/1699399307559/profile-mary-crop.jpeg)
Patient with type 2 diabetes has received a fee from Novo Nordisk Inc. for her participation.
MARY’S EXPERIENCE WITH TIR
”Time in Range definitely helped me to take better control in a sense that I was able to determine whether my treatment plan was working or if it wasn't. It's important to have the real-time data from the CGM.”
![headshot of Mary, a patient with diabetes](/diabetes/hcp-education/clinical/time-in-range/time-in-range-patient-stories/_jcr_content/root/slab_1771630399_copy/content/container_copy/container_copy/image.img.png/1699399311879/profile-mary-circle.png)
42 years
Type 2 diabetes, Unites States